Peptides & Recovery
What Is Semaglutide? GLP-1 Receptor Agonist Research Overview
Semaglutide is a GLP-1 receptor agonist developed by Novo Nordisk and widely researched for weight loss and glycemic control. This overview covers its structure, mechanism, pharmacokinetics, and research applications.
8 min read